David Wifling

575 citations

16 papers · 275 indexed · h-index 12

Impact in

Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology
Molecular Biology
- Receptor Mechanisms and Signaling
- Chemical Synthesis and Analysis
- Pharmacological Receptor Mechanisms and Effects

Papers in ⓘ

Molecular Biology 16
- Receptor Mechanisms and Signaling 14
- Chemical Synthesis and Analysis 8
- Ion channel regulation and function 1
Cellular and Molecular Neuroscience 9
- Neuropeptides and Animal Physiology 7
- Neuroscience and Neuropharmacology Research 2

Co-authors: Günther Bernhardt (9 shared papers)Armin Buschauer (8 shared papers)Max Keller (8 shared papers)Peter Gmeiner (6 shared papers)Harald Hübner (4 shared papers)Timothy Clark (4 shared papers)Roland Seifert (2 shared papers)Stefan Dove (1 shared paper)
Journals: Journal of Medicinal Chemistry (7 papers)European Journal of Medicinal Chemistry (2 papers)PLoS ONE (2 papers)ACS Omega (1 paper)ChemistryOpen (1 paper)
Partner nations: Germany United States United Kingdom

In The Last Decade

David Wifling

16 papers receiving 274 citations

Peers

Countries citing papers authored by David Wifling

Since Specialization

Citations

This map shows the geographic impact of David Wifling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wifling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wifling more than expected).

Fields of papers citing papers by David Wifling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wifling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wifling. The network helps show where David Wifling may publish in the future.

Co-authors

The 25 scholars most cited alongside David Wifling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Wifling Line = papers co-authored together David Wifling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Mimicking of Arginine by FunctionalizedN^ω-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples Journal of Medicinal Chemistry ·Max Keller, Kilian Kuhn, Jürgen Einsiedel, Harald Hübner, Sabrina Biselli, Catherine Mollereau, David Wifling, Jaroslava Svobodová, Günther Bernhardt, Chiara Cabrele, Patrick Vanderheyden, Peter Gmeiner, Armin Buschauer	2016	34
2	The Extracellular Loop 2 (ECL2) of the Human Histamine H4 Receptor Substantially Contributes to Ligand Binding and Constitutive Activity PLoS ONE ·David Wifling, Günther Bernhardt, Stefan Dove, Armin Buschauer	2015	29
3	Molecular determinants for the high constitutive activity of the human histamineH₄receptor: functional studies on orthologues and mutants British Journal of Pharmacology ·David Wifling, K Löffel, Uwe Nordemann, Andreas Strasser, G. Bernhardt, S. Dove, Roland Seifert, Armin Buschauer	2014	29
4	Luciferase Reporter Gene Assay on Human, Murine and Rat Histamine H4 Receptor Orthologs: Correlations and Discrepancies between Distal and Proximal Readouts PLoS ONE ·Uwe Nordemann, David Wifling, David Schnell, Günther Bernhardt, Holger Stark, Roland Seifert, Armin Buschauer	2013	23
5	Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine H₂ Receptor Agonists ACS Omega ·Steffen Pockes, David Wifling, Max Keller, Armin Buschauer, Sigurd Elz	2018	23
6	UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H₃ and H₄ Receptors Journal of Medicinal Chemistry ·Edith Bartole, Lukas Grätz, Timo Littmann, David Wifling, Ulla Seibel, Armin Buschauer, Günther Bernhardt	2020	22
7	Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M₂ Muscarinic Acetylcholine Receptor Journal of Medicinal Chemistry ·Andrea Pegoli, Xueke She, David Wifling, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	2017	20
8	Universal Activation Index for Class A GPCRs Journal of Chemical Information and Modeling ·Passainte Ibrahim, David Wifling, Timothy Clark	2019	18
9	Water-soluble inhibitors of ABCG2 (BCRP) – A fragment-based and computational approach European Journal of Medicinal Chemistry ·F Antoni, David Wifling, Günther Bernhardt	2020	14
10	Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M₂ Receptor Journal of Medicinal Chemistry ·Xueke She, Andrea Pegoli, Corinna G. Gruber, David Wifling, Jessica Carpenter, Harald Hübner, Mengya Chen, Jianfei Wan, Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday, Max Keller	2020	13
11	N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y₄ Receptor Ligands Results in Picomolar Binding Constants Journal of Medicinal Chemistry ·Adam Konieczny, Marcus Conrad, Fabian J. Ertl, Jakob Gleixner, Albert O. Gattor, Lukas Grätz, Maximilian F. Schmidt, Eduard Neu, Anselm H. C. Horn, David Wifling, Peter Gmeiner, Timothy Clark, Heinrich Sticht, Max Keller	2021	13
12	Oligopeptides as Neuropeptide Y Y₄ Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide Antagonist Journal of Medicinal Chemistry ·Adam Konieczny, Diana Braun, David Wifling, Günther Bernhardt, Max Keller	2020	11
13	Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M₂R Selectivity Journal of Medicinal Chemistry ·Andrea Pegoli, David Wifling, Corinna G. Gruber, Xueke She, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	2019	10
14	Basal Histamine H₄ Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif Chemistry - A European Journal ·David Wifling, Christopher Pfleger, Jonas Kaindl, Passainte Ibrahim, Ralf C. Kling, Armin Buschauer, Holger Gohlke, Timothy Clark	2019	7
15	Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2R selectivity European Journal of Medicinal Chemistry ·Corinna. G. Weinhart, David Wifling, Maximilian F. Schmidt, Eduard Neu, Carina Höring, Timothy Clark, Peter Gmeiner, Max Keller	2021	5
16	Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands^† ChemistryOpen ·Steffen Pockes, David Wifling, Armin Buschauer, Sigurd Elz	2019	4

About David Wifling

David Wifling is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Immunology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 16 papers that have together received 275 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Chemical Synthesis and Analysis (8 papers), Mast cells and histamine (7 papers), Neuropeptides and Animal Physiology (7 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Pancreatic function and diabetes (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (119 citations), Molecular Biology (244 citations), Immunology (72 citations), Radiology, Nuclear Medicine and Imaging (38 citations) and Endocrine and Autonomic Systems (11 citations). David Wifling has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Günther Bernhardt, Armin Buschauer, Max Keller, Peter Gmeiner, Harald Hübner, Timothy Clark, Roland Seifert, Stefan Dove, Sigurd Elz and Steffen Pockes. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, PLoS ONE, ACS Omega and ChemistryOpen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact